These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27026797)

  • 1. Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(2):1-77. PubMed ID: 27026797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(1):1-51. PubMed ID: 27026796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations.
    Duarte RV; Lambe T; Raphael JH; Eldabe S; Andronis L
    Pain Pract; 2018 Jun; 18(5):666-686. PubMed ID: 29064620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 10-kHz High-Frequency Spinal Cord Stimulation for Adults With Chronic Noncancer Pain: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(6):1-109. PubMed ID: 32194881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
    Ontario Health
    Ont Health Technol Assess Ser; 2024; 24(2):1-162. PubMed ID: 38344326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketamine as an adjuvant to opioids for cancer pain.
    Bell RF; Eccleston C; Kalso EA
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003351. PubMed ID: 28657160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients.
    Bolash R; Udeh B; Saweris Y; Guirguis M; Dalton JE; Makarova N; Mekhail N
    Neuromodulation; 2015 Feb; 18(2):150-5; discussion 155-6. PubMed ID: 25250852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Opioid Reduction and Discontinuation Following Implantation of Intrathecal Drug-Delivery Systems for Chronic Pain: A Retrospective Cohort Analysis.
    Hatheway JA; Bansal M; Nichols-Ricker CI
    Neuromodulation; 2020 Oct; 23(7):961-969. PubMed ID: 31603605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal drug delivery systems for the management of chronic non-cancer pain: protocol for a systematic review of economic evaluations.
    Duarte RV; Lambe T; Raphael JH; Eldabe S; Andronis L
    BMJ Open; 2016 Jul; 6(7):e012285. PubMed ID: 27421298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated mandatory bolus versus basal infusion for maintenance of epidural analgesia in labour.
    Tan HS; Zeng Y; Qi Y; Sultana R; Tan CW; Sia AT; Sng BL; Siddiqui FJ
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD011344. PubMed ID: 37276327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal Drug Delivery for the Treatment of Cancer-Associated Chronic Pain in Children.
    Kenfield M; Zacharias N; Abd-Elsayed A
    Neuromodulation; 2023 Aug; 26(6):1153-1163. PubMed ID: 34520605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal Drug Delivery.
    De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trialing and Maintenance Dosing Using a Low-Dose Intrathecal Opioid Method for Chronic Nonmalignant Pain: A Prospective 36-Month Study.
    Grider JS; Etscheidt MA; Harned ME; Lee J; Smith B; Lamar C; Bux A
    Neuromodulation; 2016 Feb; 19(2):206-19. PubMed ID: 26477685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.
    Grider JS; Harned ME; Etscheidt MA
    Pain Physician; 2011; 14(4):343-51. PubMed ID: 21785477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective, Randomized, Single-Blinded, Head-to-Head Long-Term Outcome Study, Comparing Intrathecal (IT) Boluses With Continuous Infusion Trialing Techniques Prior to Implantation of Drug Delivery Systems (DDS) for the Treatment of Severe Intractable Chronic Nonmalignant Pain.
    Hamza M; Doleys DM; Saleh IA; Medvedovsky A; Verdolin MH; Hamza M
    Neuromodulation; 2015 Oct; 18(7):636-48; discussion 649. PubMed ID: 26307558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
    Herring EZ; Frizon LA; Hogue O; Mejia JU; Rosenquist R; Bolash RB; Machado AG; Nagel SJ
    Pain Med; 2019 Mar; 20(3):515-520. PubMed ID: 29889241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structured Education and Neuromuscular Exercise Program for Hip and/or Knee Osteoarthritis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(8):1-110. PubMed ID: 30443280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.